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Feline infectious peritonitis (FIP) is a fatal disease caused by feline coronavirus (FCoV) infection. FCoV can be divided
into serotypes I and II. The virus that causes FIP (FIPV) is believed to occur sporadically and spread infrequently from
cat to cat. Recently, an FIP outbreak from an animal shelter was confirmed in Taiwan. FCoV from all the cats in this
shelter were analyzed to determine the epidemiology of this outbreak. Thirteen of 46 (28.2%) cats with typical signs
of FIP were identified. Among them, seven cats were confirmed by necropsy and/or histopathological
examinations. Despite the fact that more than one FCoV was identified in this multi-cat environment, the eight FIP
cats were invariably found to be infected with a type II FCoV. Sequence analysis revealed that the type II FIPV
detected from fecal samples, body effusions and granulomatous tissue homogenates from the cats that succumbed
to FIP all harbored an identical recombination site in their S gene. Two of the cats that succumbed to FIP were
found to harbor an identical nonsense mutation in the 3c gene. Fecal shedding of this type II virus in the effusive
form of FIP can be detected up to six days before death. Taken together, our data demonstrate that horizontal
transmission of FIPV is possible and that FIP cats can pose a potential risk to other cats living in the same
environment.Introduction
Feline infectious peritonitis (FIP) is a fatal disease in cats
caused by feline coronavirus (FCoV). FCoV is an
enveloped, positive-stranded RNA virus belonging to
genus Alphacoronavirus, family Coronaviridae, within
the order Nidovirales. The genome size of FCoV is ap-
proximately 28.9 kb, including a non-structural replicase
gene; four structural genes encoding the spike (S), enve-
lope, membrane and nucleocapsid proteins; and five
accessory genes 3abc and 7ab [1].
Feline coronaviruses cause mild to inapparent and
transient infections of the gut and are ubiquitous in cat
populations worldwide [2]. They exist in two serotypes, I
and II [3]. Type I FCoV is predominant in the field,
whereas type II virus represents only 2-30% of infection* Correspondence: linglingchueh@ntu.edu.tw
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reproduction in any medium, provided the or[4-8]. Accumulating genetic evidence indicates that type
II FCoV have arisen by two homologous recombinations
between type I FCoV and canine CoV (CCoV) [9,10].
Both serotypes can mutate in the host to acquire macro-
phage tropism and cause a systemic disease known as
feline infectious peritonitis [2,11,12]. Due to a lack of
virus-shedding in studies of FIP cats, the mutant FIP
viruses (FIP causing FCoV, FIPV) are presumably
contained only within the diseased tissues and not trans-
mitted by cat-to-cat contact under natural circumstances
[2,11,13,14].
In this paper, we report herein on an epizootic of FIP
in a Taiwanese shelter that was caused by a novel type II
FCoV. Epidemiological and molecular studies of isolates
from various healthy and affected cats in this shelter
strongly suggest that this virus was brought in by the
introduction of kittens from another shelter with subse-
quent horizontal spread to co-housed adult cats.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Animals and specimen collection
A total of 46 cats from a private cat shelter were
subjected to this study from September 2011 to August
2012. The shelter houses adult cats and occasionally
some kittens. All of the cats were either stray animals or
had been rescued, and some of them were being tempor-
ally raised at the homes of various private cat rescuers.
Before this outbreak, all cats were living together in a
cageless indoor environment and shared food, water
bowls and litter boxes. Some of the cats were siblings,
and the others were unrelated (Table 1).
Feces or rectal swab samples of all asymptomatic cats
were collected at least once to monitor the presence of
FCoV. For cats showing signs of illness suspected to be
FIP, body effusions, whole blood and swab samples, in-
cluding rectal, nasal, oral and conjuctival swabs, were
collected routinely. In addition to supportive care, these
FIP-suspected animals were subjected to treatment with
prednisolone (Prelon®, YF Chemical Corp., New Taipei
City, Taiwan), benazepril (Cibacen®, Novartis, Barbera
del Valles, Spain) and recombinant human interferon
alpha (Roferon®-A, Roche, Basel, Switzerland). Cats that
succumbed to illness were subjected to necropsy for
pathological confirmation. Upon necropsy, body effusions
were first drawn by needle and syringe, followed by
collecting swabs, whole blood, urine and granulomatous
lesions in the internal organs. All samples were frozen at -
20 °C until use. All specimens were screened for FCoV by
reverse transcription-nested polymerase chain reaction
(RT-nPCR) [15]. The specimens that tested positively were
subsequently subjected to further analysis.
Sample preparation and reverse transcription
Swab samples were suspended in 1 mL of 0.1% diethyl
pyrocarbonate (DEPC)-treated water. Fecal samples were
suspended with 9 times of 0.1% DEPC-treated water by
vortexing. The suspension was centrifuged, and the
supernatant was transferred into a new tube. Approxi-
mately 0.5 g tissues were frozen and then ground with a
mortar and pestle in the presence of 2 mL of Trizol [16].
Total RNA was extracted from 300 μL of swab suspen-
sion, whole blood, fecal suspension, tissue homogenate
and body effusion using Trizol. Twenty-one microliters
of isolated RNA were reverse transcribed with template-
specific primer N1 (5′-gctacaattgtatcctcaac-3′) or P211
[15] with Moloney murine leukemia virus reverse tran-
scriptase (Invitrogen, CA, USA). The reaction was incu-
bated at 37°C for 60 min, 72°C for 15 min and finally, at
94°C for 5 min.
Typing of FCoV using nested PCR
For typing of FCoV, nested PCR was performed
according to the procedures reported by Addie et al. [5]with slight modification. Following reverse transcrip-
tion, 5 μL of the complementary DNA was added to
25 μL of the PCR mixture (Invitrogen, CA, USA)
according to the manufacturer’s instructions for the
following primer sets: S1 and Iffs for type I FCoV de-
tection and S1 and Icfs for type II FCoV detection.
Nested PCR was performed on 2 μL of the first PCR
product using nested primers. The expected size of
the second PCR yielded for type I and II FCoV were
360 and 218 bp, respectively. The products of RT-
nPCR were electrophoresed, and then, target DNA
fragments were purified (Geneaid Biotech, Ltd, Taipei)
and sequenced (Mission Biotech, Taipei, Taiwan) from
both orientations.
Amplification, sequencing and analysis of 3a and 3c gene
from the type II FCoV
To amplify the 3a gene of type II FCoV from FIP cats, a
specific primer set that can amplify from the type II S
gene to the 3a gene was designed. Complementary DNA
amplified with the primer set targeted the 3′ end of the
type II FCoV S gene (Icfs) and 5′ end of the FCoV 3a
gene (3aR2: 5′-caccaaaacctatacacacaag-3′). The temperature
cycling consisted of 5 min of preheating at 94°C; 35 cy-
cles of denaturation at 94°C for 20 s, annealing at 50°C
for 20 s and extension at 72°C for 30 s; and a final ex-
tension at 72°C for 5 min. Following a second round of
amplification with the primers nIcfs and 3aR2, the
expected size of the product was approximately 600 bp.
The amplicons were electrophoresed, purified and se-
quenced from both orientations to confirm the nucleo-
tide sequences.
To amplify the 3c gene of type II FCoV from FIP cats,
specific primer sets that can amplify from the 3′ end of the
type II S gene to the 3c gene were designed. Complemen-
tary DNA were amplified with the forward primer (Icfs)
and reverse primer (E68R: 5′-aatatcaatataattatctgctgga-3′
and/or N21R: 5′-gttcatctccccagttgacg-3′). The temperature
cycling consisted of 5 min of preheating at 94°C; 40 cycles
of denaturation at 94°C for 30 s, annealing at 46°C for
30 s and extension at 72°C for 90 s; and a final extension
at 72°C for 7 min. Following a second round of amplifica-
tion with primer nIcfs and E68R, the products were
electrophoresed, purified and sequenced from both orienta-
tions to confirm the nucleotide sequences.
Phylogenetic analysis and recombination site analysis of a
type II FCoV
Multiple sequence alignments were preformed with
ClustalW 2.0 and manually edited in EditSeq (DNASTAR,
Madison, USA). Phylogenetic analyses were conducted
using MegAlign, version 7.2.1 (DNASTAR, Madison,
USA). Bootscan and similarity graphs were prepared with
SimPlot 3.5.1 software (SCRoftware, Baltimore, USA).
Table 1 Information for all FIP-suspected and confirmed cats from the cat shelter




Date of death Clinical findings Necropsy findings Effusive/non-effusive
1 3m Jun. 16, 2011 Aug. 17, 2011 Sep. 01, 2011 Fever, anorexia, ascites, neurological signs
2a 4m Aug. 06, 2011 NA2 Sep. 21, 2011 Clinical signs unavailable
3b 3m Jul. 11, 2011 Aug. 18, 2011 Sep. 25, 2011 Fever, anorexia, weight loss, neurological signs
4 2.5m Jun. 08, 2011 Aug. 16, 2011 Sep. 28, 2011 Fever, ascites, neurological signs
5a 4m Aug. 06, 2011 Aug. 15, 2011 Oct. 20, 2011 Fever, pleural effusion, diarrhea
6 7m Apr. 24, 2011 NA Oct. 22, 2011 Anorexia, weight loss, neurological signs
7 3y6m Resident NA Oct. 27, 2011 Ascites, jaundice, granulomatous lesion in kidney,
fibrinous peritonitis
Effusive
8 6m Jul. 11, 2011 NA Dec. 14, 2011 Granulomatous changes in kidney, liver, lung, brain
and eyes
Non-effusive
9 2y Resident NA Dec. 28, 2011 Ascites, pleural effusion and pericardial effusion,
granulomatous changes in kidney, liver and intestine
Effusive/non-effusive
10b 3m Jul. 11, 2011 NA Nov. 05, 2011 Granulomatous changes in kidney, liver and omentum Non-effusive
11c 1y6m Resident NA Feb. 14, 2012 Ascites and pleural effusion, jaundice, fibrinous peritonitis,
granulomatous changes in kidney, liver, lung and spleen.
Effusive/non-effusive
12c 1y6m Resident NA Mar. 19, 2012 Jaundice, fibrinous peritonitis, granulomatous changes in
thoracic and abdominal wall, kidney, liver, lung, spleen
omentum, and eyes.
Effusive/non-effusive
13 1y7m Resident NA Apr. 13, 2012 Jaundice, enlargement of liver and mesenteric lymph
node, granulomatous changes in kidney and lung.
Non-effusive
1 Age of the cats when clinical signs of FIP appeared.
2 Not available.















Table 2 Detection and typing of FCoV in fecal samples
from healthy cats in the same shelter
No. FCoV Type
Oct. 2011 Feb. 2012 Jun. 2012 Jul. 2012
14 ++ ++ ++ + untypable
15 - + - untypable
16 ++ - - untypable
17 ++ ++ + ++ I
18 ++ ++ ++ ++ I
19 - - + untypable
20 - - + untypable
21 - - -
22 ++ ++ - untypable
23 + ++ - + I
24 - + - untypable
25 ++ ++ + + I
26 - + - untypable
27 ++ ++ + + I
28 ++ ++ ++ + I
29 - - -
30 - ++ ++ - I
31 - -
32 + ++ - - I
33 - ++ - untypable
34 ++ I
35 - + + untypable
36 ++ ++ + - I
37 -
38 + untypable
39 ++ + + I
40 - + - untypable
41 + - + untypable





++: FCoV detected in the first round of PCR.
+: FCoV detected only in the nested PCR.
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Confirmation of an FIP outbreak in the cat shelter
The shelter had been ongoing for three-and–a-half years.
No history of FIP was recorded before August 2011. Kit-
tens (cat 1, 3, 4, 8 and 10) were introduced to this shel-
ter between June and July 2011. After entering, these
kittens played together and lived with the resident adult
cats. Before the outbreak, the kittens were taken indi-
vidually to a veterinarian for vaccinations and attended
adoption activities. Fever was first observed in four of
the kittens (cat 1, 3, 4, 5) within a period of a few days
(from August 15th to 18th) (Table 1). Clinical signs, e.g.,
fever, anorexia, neurological signs, panting and/or ab-
dominal extension were observed for the following two
months and the kittens died sequentially between
September 1st and October 22nd (Table 1). The care-
givers at the shelter requested our help on September
27th. All of the resident cats in the shelter were immedi-
ately screened for FCoV using RT-nPCR. All FCoV posi-
tive cats were isolated individually and kept separated.
Nevertheless, starting in September, some of the adult
cats with FIP (cats 7-13) showed clinical signs similar to
those of the kittens and all of them died later.
Six kittens (cats 1-6) with body effusions and/or neuro-
logical signs succumbed within the first two months
without necropsy confirmation (Table 1). Cat 1 was
once presented to our teaching hospital, and ascites
was taken from the cat. In cats 7-13, typical necropsy
features, characterized by ascites and/or pleural effu-
sions in the body cavities (effusive FIP) and granuloma-
tous lesions in several organs, especially the kidney,
liver, lung, omentum and eyes (non-effusive FIP), were
found. Cats 9, 11 and 12 manifested mixed forms of the
disease at necropsy (Table 1).
Altogether, 13 of 46 cats (28.3%) died from FIP be-
tween September 2011 and April 2012. During this
period, 33 cats (71.7%) appeared to be clinically healthy,
and 26 of these asymptomatic cats (78.7%) were positive
at least once for FCoV detection in their feces by RT-
nPCR. The other seven of these asymptomatic cats were
negative for FCoV detection (Table 2).
Type II FIPV were consistently detected in the FIP-
succumbed cats
To further investigate the relationship between these
seven histopathologically confirmed FIP cats, amplified
DNA were typed, sequenced and analyzed. Type II FIPV
were detected in all eight of the animals that succumbed
to FIP in their swab samples, feces, urine, body effusions,
cerebrospinal fluids and tissue homogenates (Table 3).
Type II viruses that cause FIP were found not only in
the diseased tissue but also in the fecal samples (cat 7,
11, 12 and 13), nasal/oral/conjunctival swab samples (cat
7, 8, 9, 11 and 12), and urine collected by cystocentesis(cat 11) (Table 3). Although there was no necropsy, the
ascites from cat 1, the first FIP death in this cat shelter,
was available for analysis. This cat was confirmed to be
infected with a type II virus. From the healthy animals,
only type I or untypable FCoV were detected from the
fecal samples (Table 2). Cats 8, 9 and 13 were co-
infected with both types of FCoV (Table 3). Although
more than one FCoV, i.e., type I, II or untypable viruses,
was found to circulate in this multi-cat environment, the
Table 3 The characteristics of 3c genes of FCoV recovered from various specimens of FIP cats
Case
no.
Genotype of FCoV S gene
crossover
site
Integrity of the 3c geneb
NOC R/F U A/P CSF Li Lu Ki Br Sp Int R/F A/P Li Lu Ki Br Sp
1 II 4250a intact
7 II II II II II II II II 4250 intact intact intact intact intact
8 II I + II II + - -
9 II I II + II II II + 4250 G210* G210* G210*
10 + + II II II 4250 intact
11 II II II II + II II II + 4250 E47*
12 II II II II + II II II + 4250 G210* G210*
13 I/II + + + II II + 4250 Q218*
NOC, nasal/oral/conjunctival swabs; R/F, rectal swabs or fecal samples; A/P, ascites or pleural effusions; CSF, cerebrospinal fluid; Li, liver; Lu, lung; Ki, kidney; Br,
brain; Sp, spleen; Int, intestine.
+: FCoV positive but the type of virus cannot be determined.
-: FCoV negative.
a: FCoV/NTU2/R/2003; GenBank: DQ160294.
b: E47*, G210* and Q218*: truncated 3c proteins with premature stop codons at amino acids 47, 210 and 218 were found, respectively.
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with a type II FCoV, whereas the healthy cats were not
(Tables 2 and 3).
A type II FIPV of the same origin was detected from FIP-
succumbed cats
To further investigate the relationship of these disease-
associated type II viruses isolated from FIP-succumbed
cats, specific primer sets that can specifically amplify from
the 3′ end of type II S gene to a downstream gene were
used to analyze the viral sequences. The identity of the 620
bp amplicons derived from seven type II FIPV was ap-
proximately 98.7% to 99.8%. Phylogenetic analysis revealed
that the type II FCoV derived from this outbreak were all
grouped in a separate cluster, distinct from the other four
type II FCoV currently available in the GenBank, i.e., FIPV
79-1146 (GenBank: DQ010921), FCoV 79-1683 (GenBank:
JN634064), FCoV DF-2 (GenBank: DQ286389) and FCoV
NTU156 (GenBank: GQ152141) (data not shown).
A recombination event at the 3′ end of the S gene
with the putative recombination site located at nucleo-
tide 4250 was identified from all of the type II FCoV
derived from the body effusions and tissue homogenate
of cats 1, 7, 9, 10, 11, 12 and 13 (Additional file 1)
(Table 3). Sequences upstream from this site show a
higher similarity to CCoV, whereas sequences down-
stream from this site were more similar to type I FCoV
(Figure 1). These findings highly suggest that the type
II FCoV recovered from all of the FIP cats were from a
common origin.
An identical nonsense mutation in 3c gene was found in
two FIP-succumbed cats
To further analyze the relationship of these FIPV, 3c
genes, the proposed virulence-associated factor of FIP,were amplified from disease-related type II FCoV. Mu-
tated 3c genes with an identical premature stop codon at
nucleotides 628-630 (amino acid 210, G210*) were found
in two FIP cats, including cats 9 (ascites, spleen and
brain) and 12 (ascites and rectal swabs from the day it
succumbed and four days before) (Figure 2A). It is note-
worthy that the FIPV shed from cat 12 harbored an
identical nonsense mutation as the virus in its ascites.
Intact 3c genes were detected from cats 1, 7 and 10,
which had previously succumbed to FIP. Two more dis-
tinct nonsense mutations were identified from cats 11
(E47*) and 13 (Q218*) (Figure 2A-B, Table 3).
Shedding of the type II FIPV can be detected at the
terminal stage of FIP cats
The presence of FCoV was continuously analyzed to elu-
cidate the possible route of shedding and transmission
of FIPV. Disease-associated type II FCoV were found to
shed through nasal/oral/conjunctival and fecal routes
(Table 4). Fecal and nasal/oral/conjunctival shedding of
this type II virus can be detected from the 6th day (cat
11) and 4th day (cat 12) respectively, before death.
Viremia could be detected during the terminal stage in
the cats with FIP, up to 18 days before death, and simul-
taneous fecal shedding was noted in one cat (cat 12)
(Table 4).
Discussion
The possibility of horizontal transmission in FIP is gen-
erally questioned because (i) the occurrence of FIP is
sporadic, and a single cat developing FIP in a multi-cat
environment is common [2]; (ii) the internal mutation
theory, which describes that FIPV is a mutant generated
from enteric FCoV in one cat [12,17]; (iii) there is a lack
of evidence of mutant FIPV shedding from FIP cats; and
Figure 1 Recombination of FIPV from cats 1, 7, 9, 10, 11, 12 and 13 on the S gene. The alignment of the 3′ end of the S gene to the
downstream genes of FCoV isolated from seven FIP cats with type I FCoV and CCoV. The light and dark shaded areas encompass higher similarity
to CCoV and type I FCoV, respectively. The putative recombination event occurred at nucleotide 4250 based on the comparison with FCoV NTU2
and is indicated with an arrow. The sequences were obtained from FIPV found in individual samples and tissues and are shown collectively. NOC:
nasal/oral/conjunctival swabs; RS: rectal swabs; As: ascites; PE: pleural effusion; Li: liver; Lu: lung; Ki: kidney; Br: brain; Sp: spleen; dbd: days before
death. GenBank accession number: FCoV C1Je (GenBank: DQ848678), FCoV Black (GenBank: EU186072), FCoV NTU2 (GenBank: DQ160294) and
CCoV NTU336 (GenBank: GQ477367).
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cat [11,13,18]. The current belief is that cats that suc-
cumb to FIP do not shed and transmit the FIPV to other
cats [11,13,14,18-20]. Our data indicate that this out-
break of FIP was caused by viruses from the same origin.
First, all of the FIP losses involved a type II FIPV infec-
tion, and the recombination event of these seven type II
viruses was mapped to the same site. The recombination
sites of the type II viruses currently available in
GenBank, i.e., FIPV 79-1146, FCoV 79-1683 and FCoV
NTU156, were all unique and occurred independently
[9,10]. Second, the FIPV identified in the three kittens
that died within the first two months after the onset of
fever harbored an intact 3c gene, whereas the viruses
from the cats that survived longer (died four to eight
months later) all bore a nonsense mutation, i.e., G210*
(cat 9 and 12), E47* (cats 11) and Q218* (cat 13). Be-
cause the three nonsense mutations detected in the FIPV
from these animals were all located at different sites, the
viruses that originally infected these cats should all
harbor an intact 3c gene - like the virus recovered from
the kittens that succumbed earlier. After infection, point
mutations arose during the replication of the virus in the
individual cats, giving rise to FIPV with a 3c genebearing nonsense mutations at different locations. The
finding that the viruses that were identified not only in
the tissues but also in the fecal samples of two cats (cat
9 and 12) harbored an identical mutation in the 3c gene
further confirmed that horizontal transmission had oc-
curred (Table 3). Taken together, all these findings dem-
onstrated that a highly virulent FIPV had spread from
animal to animal in a horizontal manner.
This is the first report of a type II FIPV outbreak
with evidence of horizontal transmission of a disease-
associated FCoV. The outbreak of FIP started after intro-
ducing five kittens (cat 1, 3, 4, 8 and 10) into this shelter
between June and July of 2011. Because the causative
type II viruses with the distinct genetic marker in the S
gene were confirmed to be a recombinant of feline and
canine coronaviruses and some of the kittens that died
earlier were found to have been living closely with dogs
between being rescued and entering the shelter, any of
these kittens could have been the source of this type II
virus. Dogs, and especially young dogs, in shelters often
shed large amounts of canine coronavirus in their
feces and recombination between cat and dog and dog
and pig coronaviruses has been well documented
[21-23]. Additionally, these causative type II viruses
Figure 2 Alignment of complete 3c genes of FIPV from cats 1, 7, 9, 10, 11, 12 and 13. (A) Full-length 3c genes analyzed in this study were
aligned with a type I FCoV, FCoV NTU2. The sequences were obtained from FIPV found in individual samples and tissues and are shown
collectively. A box represents identified premature stop codons. (B) Scheme shows the location of premature stop codons (PT) of 3c gene of
various specimens from different FIP cats.
Table 4 Shedding and serotypes of feline coronavirus detected in FIP cats in the cat shelter
Cat
no.
Sample Days before death
−80 −66 −60 −57 −50 −43 −36 −29 −25 −23 −20 −18 −14 −12 −8 −6 −4 0*
9 Feces I I II
NOC swabs II
Viremia II +
Effusions II II II
11 Feces - - - II II
NOC swabs - - II
Viremia - - - - -
Effusions + II
12 Feces - + - - - - - - - - - - + II II
NOC swabs - - - - - - - - - - II II
Viremia - - - - - - - - - II + + -
Effusions II II
+: FCoV positive; -: FCoV negative.
I, II: Type I or type II FCoV.
*: Samples were collected directly prior to euthanasia, except for cat 12, from which the samples were taken after death.
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dying of FIP (Table 3), thus providing a vehicle for cat-
to-cat spreading.
Although directly following the first FCoV screening
of all the animals in this shelter, cats shedding FCoV
were caged separately, and transmission subsequently
ceased, the mortality rate for this outbreak was high
(28%, 13/46). Three studies regarding outbreak of FIP
have been reported previously. In a four-year study
conducted in a closed breeding cattery, the average
mortality was 17.3% [24], and in a 10-year study of a
closed breeding colony, the mortality was 29.4% (5/17)
[25]. Another epidemic study conducted in seven cat-
teries/shelters revealed a > 10% mortality rate [20]. The
high incidence of FIP in those closed breeding colonies
might be influenced by the genetically predisposed
breeding stock. In our study, only several FIP cats in
this shelter were siblings, and the others were genetic-
ally unrelated. Our study demonstrates that without the
influence of genetic predisposing factors, the mortality
of FIP can still be high in a closed multi-cat environ-
ment as long as the spread of the disease-associated
FCoV remains undetected.
In this multi-cat environment, three of the FIP cats
were infected with not only type II FCoV but also co-
infected with type I FCoV (Table 3). Type I FCoV were
found only in the fecal samples, whereas type II FCoV
were found in the diseased-associated samples, including
body effusion, granulomatous tissue homogenates and
cerebrospinal fluid. This finding indicates that in these
dually infected animals, type II FCoV was the main
cause of FIP. This finding is consistent with our previous
finding that infection with type II FCoV appears to be
significantly correlated with FIP [4].
The presence of FCoV in the whole blood at the ter-
minal stage has been observed previously [26,27]; how-
ever, to our knowledge, fecal shedding of FIPV before
the end stage of the disease has not been reported prior
to this study. Shedding of this type II virus through fecal
and nasal/oral/conjunctival routes can be detected in ef-
fusive form FIP up to six days before death. Another ex-
perimental infection study showed that inoculated
viruses could only be recovered for approximately two
weeks after inoculation, before clinical signs of disease
develop [14]. Taken together, the transmission of FIPV
might occur at the onset, before disease manifestation
and at the terminal stage. In this outbreak, all the cats
were housed together in an open room at the very be-
ginning. After seven cats succumbed sequentially, all
FCoV-positive cats were caged individually, and kept
separated. The isolation eventually terminated the trans-
mission of the disease. This outbreak, which killed 13
cats, allowed us to determine clearly that FIPV could be
transmitted horizontally and showed that isolation ofdiseased cats should be taken into consideration in a
multi-cat environment.
Additional file
Additional file 1: Recombination site analysis of FIPV from cats 1, 7,
9, 10, 11, 12 and 13 on the S gene. Similarity plot analysis with the
Kimura (two-parameter) distance model, neighbor-joining tree model and
100 bootstrap replicates showed a recombination event, and the putative
crossover site is indicated with an arrow.
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